Lansoprazole, Clarithromycin, Amoxicillin

H.Bacter

BrazilCancelledAuthorised 8 Jul 2002

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Aa-Lansoprazole-Amoxicillin-ClarithromycinCanada · 500 MG / CAP + 500 MG / TAB + 30 MG / CAP · Capsule, Capsule (Delayed-Release), Kit, Tablet · Aa Pharma INCSame substance
HP-PacCanada · 500 MG / CAP + 500 MG / TAB + 30 MG / CAP · Capsule, Capsule (Delayed-Release), Kit, Tablet · Takeda Pharmaceuticals America INCSame substance
Lansoprazole, Amoxicillin and Clarithromycin (Copackaged)United States · 500MG; 500MG; 30MG · capsule, tablet, capsule, delayed rel pellets · RisingSame substance
Prevpac (Copackaged)United States · 500MG; 500MG; 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · capsule, tablet, capsule, delayed rel pellets · Takeda Pharms USASame substance

Sources and licences

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lansoprazole, Clarithromycin, Amoxicillin

H.Bacter

BrazilCancelledAuthorised 8 Jul 2002

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Sources and licences

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Lansoprazole, Clarithromycin, Amoxicillin
Register: Brazil (Anvisa)
Status: Cancelled
Status in the register: Inativo
Authorised: 8 Jul 2002
Registration: 115600109
Marketing authorisation holder: Cifarma Científica Farmacêutica Ltda
Procedure: Registered

lansoprazol +claritromicina +amoxicilinaLansoprazole + Clarithromycin + AmoxicillinBrazil

PyloripacLansoprazole + Clarithromycin + AmoxicillinBrazil

PyloritratLansoprazole + Clarithromycin + AmoxicillinBrazil

AnzopacLansoprazole + Clarithromycin + AmoxicillinBrazilCancelled

H.BacterLansoprazole + Clarithromycin + AmoxicillinBrazilCancelled

HelicopacLansoprazole + Clarithromycin + AmoxicillinBrazilCancelled

ImbysLansoprazole + Clarithromycin + AmoxicillinBrazilCancelled

LansokitLansoprazole + Clarithromycin + AmoxicillinBrazilCancelled

LansomixLansoprazole + Clarithromycin + AmoxicillinBrazilCancelled

Lansoprazol + Claritromicina + Amoxicilina TrihidratadaLansoprazole + Clarithromycin + AmoxicillinBrazilCancelled